Abstract
Fluorine continues to show its potential applications in drug discovery and development, as reflected by twelve drugs being fluorinated out of the fifty-five approved by the FDA in 2023. This concise review highlights the discovery of each of these fluorine-containing drugs in the past year, including its brand name, date of approval, composition, sponsors, indication, and mechanism of action. The relevant future trend is also briefly discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 843-849 |
| Number of pages | 7 |
| Journal | Current topics in medicinal chemistry |
| Volume | 24 |
| Issue number | 10 |
| DOIs | |
| State | Published - 2024 |
Keywords
- Diagnostic tools
- FDA approval
- Fluorinated drugs
- Fluorine
- Small-molecule drug discovery
- Therapeutics
ASJC Scopus subject areas
- Drug Discovery
Fingerprint
Dive into the research topics of 'Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS